These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37842565)

  • 1. Molecular subtypes based on N6-methyladenosine RNA methylation demonstrate the heterogeneity of immune and biological functions in pediatric septic shock.
    Wang H; Huang J; Guo C; Wu J; Zhang L; Ren X; Gan L
    Heliyon; 2023 Oct; 9(10):e20714. PubMed ID: 37842565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S; Hua R; Quan S
    J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
    Li S; Liu H; Ruan Z; Guo R; Sun C; Tang Y; Huang X; Gao T; Hao S; Li H; Song N; Su Y; Ning F; Li Z; Chang T
    J Transl Med; 2023 Mar; 21(1):166. PubMed ID: 36864526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.
    Fu C; Feng L; Zhang J; Sun D
    Ann Transl Med; 2022 May; 10(10):547. PubMed ID: 35722410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insight of N
    Wang K; Kan Q; Ye Y; Qiu J; Huang L; Wu R; Yao C
    Front Genet; 2022; 13():1055396. PubMed ID: 36482903
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
    Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
    Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
    Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
    Front Genet; 2022; 13():1044264. PubMed ID: 36544487
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment.
    He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S
    Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
    Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
    Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma.
    Li S; Li Q; Zhang L; Qi Y; Bai H
    Biophys Rep; 2023 Jun; 9(3):146-158. PubMed ID: 38028153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of m6A-related diagnostic model for psoriasis.
    Liu J; Wang Y; Sheng Y; Cai L; Wang Y
    PeerJ; 2024; 12():e17027. PubMed ID: 38436011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A Regulator-mediated RNA Methylation Modulates Immune Microenvironment of Hepatitis B Virus-related Acute Liver Failure.
    Li D; Liu Y; Zhou J; Chen Y; Yang C; Liu H; Li W; You J
    Inflammation; 2023 Oct; 46(5):1777-1795. PubMed ID: 37256461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
    Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
    Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
    Hao X; Li Y; Huang G; Zeng Y
    Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A Regulator-Mediated RNA Methylation Modification Patterns are Involved in the Pathogenesis and Immune Microenvironment of Depression.
    Wang Y; Wang X; Yang C; Hua W; Wang H
    Front Genet; 2022; 13():865695. PubMed ID: 35480327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
    Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
    Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
    Quan Y; Zhang X; Ping H
    Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.